BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 804435)

  • 1. Role of antibodies to galactocerebroside in experimental allergic encephalomyelitis.
    Hughes RA; Leibowitz S
    Immunology; 1975 Feb; 28(2):213-8. PubMed ID: 804435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of rats from experimental allergic encephalomyelitis with antiserum to guinea-pig spinal cord.
    Hughes RA
    Immunology; 1974 Apr; 26(4):703-11. PubMed ID: 4212280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The susceptibility of rat strains to experimental allergic encephalomyelitis.
    Hughes RA; Stedronska J
    Immunology; 1973 May; 24(5):879-84. PubMed ID: 4715260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide.
    MacPhee IA; Day MJ; Mason DW
    Immunology; 1990 Aug; 70(4):527-34. PubMed ID: 1697565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
    Whitacre CC; Paterson PY
    J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of homologous and heterologous carriers on the immunogenicity of the galactocerebroside hapten.
    Czlonkowska A; Leibowitz S
    Immunology; 1974 Dec; 27(6):1117-26. PubMed ID: 4217778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats.
    Levine S; Sowinski R
    J Immunol; 1975 Feb; 114(2 Pt 1):597-601. PubMed ID: 1120901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of myelin antigens in murine relapsing experimental allergic encephalomyelitis.
    Lublin FD
    J Clin Lab Immunol; 1984 Apr; 13(4):179-82. PubMed ID: 6204053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunoluminescent study of the sera of guinea pigs with experimental allergic encephalomyelitis].
    Zhitnukhin IuL; Zubzhitskiĭ IuN
    Biull Eksp Biol Med; 1972 Aug; 73(8):63-5. PubMed ID: 4564367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomorphological characteristics of experimental allergic encephalomyelitis induced by an encephalitogenic polypeptide].
    Zhitnukhin IuL; Khizhniak MG
    Biull Eksp Biol Med; 1987 Mar; 103(3):343-6. PubMed ID: 2435338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1974 Jan; 112(1):392-7. PubMed ID: 4130152
    [No Abstract]   [Full Text] [Related]  

  • 12. Modified EAE as an assay for immunosuppressant drugs.
    Beck FW; Whitehouse MW
    Proc West Pharmacol Soc; 1975; 18():136-40. PubMed ID: 809779
    [No Abstract]   [Full Text] [Related]  

  • 13. The susceptibility of several inbred strains of rats to adjuvant-induced arthritis and experimental allergic encephalomyelitis.
    Perlík F; Zídek Z
    Z Immunitatsforsch Exp Klin Immunol; 1974 Jun; 147(2):191-3. PubMed ID: 4283010
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
    Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
    Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin antigen-coupled splenocytes suppress experimental autoimmune encephalomyelitis in Lewis rats through a partially reversible anergy mechanism.
    Vandenbark AA; Celnik B; Vainiene M; Miller SD; Offner H
    J Immunol; 1995 Dec; 155(12):5861-7. PubMed ID: 7499876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the protective effect of cerebroside injections on experimental allergic encephalomyelitis].
    Niedieck B; Kuck U
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Jun; 133(1):43-9. PubMed ID: 4232425
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
    Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
    J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties, and specificity of the serum-demyelinating factor.
    Lebar R; Boutry JM; Vincent C; Robineaux R; Voisin GA
    J Immunol; 1976 May; 116(5):1439-46. PubMed ID: 58035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further studies on the inhibition of allergic encephalomyelitis by L-asparaginase.
    Khan A; Levine S
    J Immunol; 1974 Jul; 113(1):367-70. PubMed ID: 4134065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.